Rational Combination Therapy of AML |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD, PhD |
'A' Award Grants |
2013 |
New York |
Engineering the Lymph Node Environment with Therapeutic Vaccine Depots to Combat Neuroblastoma |
University of Maryland, College Park / Christopher Jewell, PhD |
'A' Award Grants |
2013 |
Maryland |
Investigating the Role of Genetic and Epigenetic Variation in Risk of Childhood Acute Lymphoblastic Leukemia in Down Syndrome |
University of California San Francisco / Adam de Smith, Ph.D. |
'A' Award Grants |
2014 |
California |
Uncovering the Dysregulated RNA Binding Protein Network in Childhood Acute Myeloid Leukemia |
Memorial Sloan-Kettering Cancer Center / Michael Kharas, PhD |
'A' Award Grants |
2016 |
New York |
Novel Approaches to AML Differentiation Therapy |
Dana-Farber Cancer Institute / Andrew Lane, MD/PhD |
'A' Award Grants |
2017 |
Massachusetts |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Targeting the LIN28 Pathway in ATRT |
The Johns Hopkins University School of Medicine / Eric Raabe, MD, PhD |
'A' Award Grants |
2015 |
Maryland |
WWOX as a Signal Mediator in Pediatric Osteosarcoma |
The Ohio State University / Rami Aqeilan |
'A' Award Grants |
2009 |
Ohio |
Exploiting the Differentiation Potential of Pediatric High-Grade Glioma to Discover Novel Therapeutic Opportunities |
Dana-Farber Cancer Institute / Mariella Filbin, MD/PhD |
'A' Award Grants |
2019 |
Massachusetts |